Retatrutide + Cagrilintide
Laboratory tested · see the certificate (99.70%, lot RTCAG15-0803) · peptide blends
Retatrutide, labelled 12.5 mg, with cagrilintide, labelled 2.5 mg, lyophilized in one vial. The lot certificate reports one purity figure for the vial and two measured content figures; it does not assign either figure to a component.
20% off Limited time, every size
Was $200$160/ 12.5 mg / 2.5 mg · USD
Certificate for 12.5 mg / 2.5 mg: lot RTCAG15-0803, 99.70% by RP-HPLCView certificate
Every vial ships with its lot record. The price shown is the price our fulfilment partner charges at checkout.
What the price already covers
- The testing laboratory’s certificate for each lot on file, linked from this page with a verification number you can check on the laboratory’s own site.
- Purity by reversed-phase HPLC and identity by mass spectrometry on every certificate listed.
- Measured content in milligrams, against the label, wherever the certificate reports it.
Shipping is $12.99 an order and free over $1,000, 2-Day or Overnight, United States only.
Specification
- Purity, catalogue minimum
- ≥98% by RP-HPLC at 214 nm; the measured figure is on each certificate
- Identity
- Confirmed by mass spectrometry
- CAS number
- Not a single molecule
- PubChem CID
- Not a single molecule
- Molecular formula
- Not a single molecule
- Molecular weight
- Not a single molecule
- Amino acid count
- A blend: see each component
- Sequence
- A blend: see each component
- Physical form
- Lyophilized powder, two peptides in one vial
- Solubility
- Soluble in water or dilute aqueous buffer.
- Storage
- -20 °C, desiccated
- Measured content
- Milligrams per vial, on the lot certificate
- Availability
- In stock
Two peptides in one vial: retatrutide and cagrilintide, an amylin analogue.
Certificates on file
Price
- 12.5 mg / 2.5 mg
Was $200$160
No account, no code and no quote form. The ladder is the whole of the pricing, and it is the same ladder for everybody.
Research reference
Status, checked October 13, 2026: Investigational. No FDA-approved product; Lilly plans to submit a Biologics License Application in the first quarter of 2027. The dated record.
Further reading
Questions about Retatrutide + Cagrilintide
- What is Retatrutide + Cagrilintide?
- Retatrutide + Cagrilintide is a blend of 2 components, each named on the label. Touchstone supplies it as lyophilized powder, two peptides in one vial in 12.5 mg / 2.5 mg, for laboratory research use only.
- Is Retatrutide + Cagrilintide laboratory tested?
- Yes. A certificate of analysis is on file for Retatrutide + Cagrilintide, from Bioviridian Inc., covering 12.5 mg. Each reports purity by reversed-phase HPLC and identity by mass spectrometry; the most recent shows 99.70% for lot RTCAG15-0803, and each carries a verification number that can be checked on the laboratory's own site.
- What is the regulatory status of Retatrutide + Cagrilintide?
- As of October 13, 2026: Investigational. No FDA-approved product; Lilly plans to submit a Biologics License Application in the first quarter of 2027.
- How is Retatrutide + Cagrilintide supplied and stored?
- It is supplied as lyophilized powder, two peptides in one vial. Storage: -20 °C, desiccated.
- How fast does Retatrutide + Cagrilintide ship?
- Orders placed before 2pm ET on a working day go out the same day, by 2-Day or Overnight service, and the tracking number is emailed when the label is made. Shipping is $12.99 an order and free over $1,000. United States addresses only.
- Can Retatrutide + Cagrilintide be used in people or animals?
- No. Retatrutide + Cagrilintide is sold for laboratory research use only. It is not for human or veterinary use, and it is not sold for it.
Others in peptide blends
For laboratory research use only. Not for human or veterinary use, and not sold for it. Bodily introduction of this material is prohibited.